If the provinces are asked to fund an old drug for a new indication, it would come to JODR.
For example, there are 400 drugs in the pipeline. Not all of them are unique. But there are 400 potential applications for about 60 new drugs. So Nexavar, which we've talked about for kidney cancer, could be considered next for another indication. That would also come--